Concepedia

Dose Delay Management

Dose Delay Management is a clinical management strategy within myelosuppression care that involves the systematic postponement of chemotherapy administration to allow hematologic recovery, thereby minimizing the risk of severe cytopenias and treatment-related complications.

37

Publications

1.5K

Citations

269

Authors

139

Institutions

Publications per year

2017–2026

6

Parents

Publications

37

Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices

Neelima Denduluri, Debra A. Patt, Yunfei Wang et al. · Journal of the National Comprehensive Cancer Network · 2015 · 146 citations · Full text

, , +16

Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia

Dai Chihara, Evgeny Arons, Maryalice Stetler‐Stevenson et al. · Journal of Clinical Oncology · 2020 · 103 citations · Full text

, , +13

Impact of neutropenia on delivering planned adjuvant chemotherapy: UK audit of primary breast cancer patients

Robert Leonard, David Miles, Robert Thomas et al. · British Journal of Cancer · 2003 · 99 citations · Full text

, , +17

Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)

Ola Landgren, Ajai Chari, Yaël C. Cohen et al. · Leukemia · 2020 · 98 citations · Full text

, , +17

Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?

Matti Aapro, Jeffrey Crawford, D. Kamioner · Supportive Care in Cancer · 2010 · 89 citations · Full text

, , +17

1–5 of 37

Authors

269

  1. GH
    Gary H. Lyman

    Fred Hutch Cancer Center, United States

    2 publications · 207 citations

    2

    h-index

  2. KS
    Karleen Schulze

    Queen's University, Canada

    1 publications · 77 citations

    1

    h-index

  3. LX
    Liqiang Xi

    National Cancer Institute, United States

    1 publications · 103 citations

    1

    h-index

  4. PF
    Peter F. Dixon

    Centre for Environment, Fisheries and Aquaculture Science, United Kingdom

    1 publications · 77 citations

    1

    h-index

  5. QL
    Quan Li

    Peking University, China

    1 publications · 16 citations

    1

    h-index

1–5 of 269

Institutions

139

  1. Amgen (United States)

    Thousand Oaks, United States

    5 h-index

    14 publications

    979 citations

  2. Memorial Sloan Kettering Cancer Center

    New York, United States

    3 h-index

    6 publications

    203 citations

  3. National Institutes of Health

    Bethesda, United States

    2 h-index

    21 publications

    1.8K citations

  4. University of Toronto

    Toronto, Canada

    2 h-index

    6 publications

    306 citations

  5. Cancer Care Ontario

    Toronto, Canada

    2 h-index

    11 publications

    724 citations

  6. University Health Network

    Toronto, Canada

    2 h-index

    5 publications

    281 citations

  7. Levine Cancer Institute

    Charlotte, United States

    1 h-index

    1 publications

    98 citations

  8. University of Rochester

    Rochester, United States

    1 h-index

    1 publications

    61 citations

1–8 of 139

Venues

  1. Supportive Care in Cancer

    3 publications · 162 citations

    3

    h-index

  2. PubMed

    Repository · 3 publications · 116 citations

    3

    h-index

  3. The Oncologist

    1 publications · 70 citations

    1

    h-index

  4. Experimental Hematology

    1 publications · 22 citations

    1

    h-index

  5. Current Neuropharmacology

    1 publications · 12 citations

    1

    h-index

1–5